Anti-TNF Therapy in the Treatment of Psoriasis in a Patient with Acute-on-Chronic Pancreatitis

被引:8
|
作者
Clayton, Helena [1 ]
Flatz, Lukas [1 ]
Vollenweider-Roten, Sonia
Schoepfer, Alain [2 ]
Gilliet, Michel [1 ]
Conrad, Curdin [1 ]
机构
[1] Univ Hosp CHUV, Dept Dermatol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp CHUV, Dept Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland
关键词
Psoriasis; Pancreatitis; Anti-TNF therapy; Biologicals; ALPHA; GUIDELINES; CYTOKINES; CELLS;
D O I
10.1159/000351714
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis is accepted as a multisystemic disease with several important systemic manifestations. Thus, underlying comorbidities have to be taken into account in the choice of treatment. Objective: To explore the role of anti-TNF therapy in the treatment of psoriasis in a patient with acute-on-chronic pancreatitis. Methods: Here, we present the case of a 75-year-old patient with severe psoriasis also suffering from chronic alcohol-induced pancreatitis with recurrent acute flares. A recent life-threatening episode of acute pancreatitis and ischemic liver precluded the reintroduction of methotrexate. Cyclosporine was also excluded as it has been reported to induce acute pancreatitis. Thus, an anti-TNF treatment was initiated in close collaboration with a gastroenterologist. Results: A year after starting anti-TNF therapy the patient continues to show complete clinical remission of his psoriasis. No side effects, particularly no bacterial infections, were reported. No relapses of the patient's underlying chronic pancreatitis were observed throughout the entire treatment with regular clinical and laboratory monitoring, suggesting that chronic pancreatitis is not per se a contraindication for anti-TNF therapy. Conclusion: This case study opens the way for further questioning on the role of TNF in the pathogenesis of chronic and acute pancreatitis and the use of anti-TNF therapy in its treatment. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:193 / 196
页数:4
相关论文
共 50 条
  • [1] Paradoxical reaction to anti-TNF treatment in a patient with HS and psoriasis
    Gulliver, W.
    Gulliver, S.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 21 - 21
  • [2] Anti-TNF biosimilars in psoriasis treatment
    Viguier, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (6-7): : 492 - 496
  • [3] Is psoriasis a complication of anti-TNF treatment?
    Perez-Zafrilla, Beatriz
    Garcia de Yebenes, Maria Jess
    Dauden, Esteban
    Gomez-Reino, Juan J.
    Carmona, Loreto
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S781 - S781
  • [4] Anti-TNF Agents for the Treatment of Psoriasis
    Kircik, Leon H.
    Del Rosso, James Q.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (06) : 546 - 559
  • [5] Autoimmune phenomena in anti-TNF therapy in psoriasis
    Schopf, R. E.
    Sapyega, N.
    Staubach, P.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 149 - 149
  • [6] Patient expectations of anti-TNF therapy
    McIvor, EM
    RHEUMATOLOGY, 2005, 44 : I14 - I14
  • [7] Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
    De Simone, Clara
    Amerio, Paolo
    Amoruso, Giuseppe
    Bardazzi, Federico
    Campanati, Anna
    Conti, Andrea
    Gisondi, Paolo
    Gualdi, Giulio
    Guarneri, Claudio
    Leoni, Luca
    Loconsole, Francesco
    Mazzotta, Annamaria
    Musumeci, Maria Letizia
    Piaserico, Stefano
    Potenza, Concetta
    Prestinari, Francesca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (12) : 1673 - 1682
  • [8] Combination therapy with cyclosporine A and an anti-TNFα agent (adalimumab) in the treatment of severe psoriasis
    Kerner, Miryam
    Rozenman, Dganit
    Ziv, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB161 - AB161
  • [9] Anti-TNF associated psoriasis
    Hamlin, P. J.
    Goodfield, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 308 - 309
  • [10] Aspects concerning patient adherence to anti-TNFα therapy in psoriasis: A decade of clinical experience
    Mocanu, Madalina
    Toader, Mihaela-Paula
    Rezus, Elena
    Taranu, Tatiana
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4987 - 4992